Citations

Bacterial Toxin Research Citations

We’ve gathered published citations for the past many years so that researchers can easily review at their convenience from among the thousands of published articles, how they might use our products in detail or apply these ideas to their own novel thinking for new research.

Search through, read and share our information rich citations below!

Contact us with any questions.

4918 total record number 290 records this year

To narrow your search, use one or more of the following search menus below.

To search by keyword, you may search by the cell/animal/assay/protein/research or publication
Page 52 out of 492
4918 citations found

Loss of biased signaling at a G protein-coupled receptor in overexpressed systems

Li, A;Liu, S;Huang, R;Ahn, S;Lefkowitz, RJ;

Product: Pertussis Toxin from B. pertussis, Lyophilized in Buffer

Memory Th1 cells modulate heterologous diseases through innate function

Rakebrandt, N;Yassini, N;Kolz, A;Schorer, M;Lambert, K;Rauld, C;Balazs, Z;Krauthammer, M;Carballido, J;Peters, A;Joller, N;

Product: Pertussis Toxin from B. pertussis, Lyophilized in Buffer

rTMS ameliorates depression/anxiety-like behaviors in experimental autoimmune encephalitis by inhibiting neurotoxic reactive astrocytes

Yu, C;Ruan, Y;Sun, X;Chen, C;Shen, T;Liu, C;Qiu, W;Lu, Z;Chan, SO;Wang, L;

Product: Pertussis Toxin from B. pertussis, Lyophilized (Salt-Free)

A spinal synergy of excitatory and inhibitory neurons coordinates ipsilateral body movements

Hayashi, M;Gullo, M;Senturk, G;Di Costanzo, S;Nagasaki, SC;Kageyama, R;Imayoshi, I;Goulding, M;Pfaff, SL;Gatto, G;

Product: Diphtheria Toxin, Unnicked, from Corynebacterium diphtheriae

CytoSorb hemoperfusion markedly attenuates circulating cytokine concentrations during systemic inflammation in humans in vivo

Jansen, A;Waalders, NJB;van Lier, DPT;Kox, M;Pickkers, P;

Product: LIST™ HPT™ from Escherichia coli O113

  • Experimental human endotoxemia

    All endotoxemia-related procedures were performed according to our standard continuous LPS-infusion protocol (12). In short, subjects were admitted to the research unit situated on the Medium Care department of the Radboud university medical center for approximately ten hours. Subjects had to refrain from consumption of alcohol and caffeine (24 h), and food and drinks (12 h) prior to LPS administration. Upon admission on the first LPS challenge day, two antebrachial venous cannulas were placed to allow administration of fluids, study medication and LPS. A radial artery catheter (BD Infusion Therapy Systems, Sandy, Utah, USA) was placed under ultrasound guidance to allow serial blood sampling and continuous hemodynamic monitoring. To reduce the risk of vasovagal responses (14), hydration fluids (2.5% glucose/0.45% sodium chloride) were administered as an initial prehydration bolus of 1.5L in the 45 min prior to LPS administration, and at a rate of 150 mL/hr for the remainder of the experiment. After prehydration, a bodyweight adjusted bolus dose of 1 ng/kg LPS (E. coli type O:113, lot no. 94332B1; List Biological Laboratories, Campbell, USA) was administered intravenously, directly followed by continuous infusion of LPS at a rate of 0.5 ng/kg/hr for three hours. Blood samples were serially obtained to construct time-concentration curves of circulating cytokines. Heart rate and intra-arterial blood pressure were measured using a 4-lead electrocardiogram (M50 Monitor, Philips, Eindhoven, the Netherlands) and a radial artery pressure transducer (Edwards Lifesciences, Irvine, California, USA). Hemodynamic parameters were recorded every 5 s using in-house developed software. Every 30 min, body temperature was measured using a tympanic thermometer (FirstTemp Genius 2, Covidien, Dublin, Ireland). Flu-like symptoms (headache, nausea, cold shivers, myalgia and back pain) were scored every 30 min using a numeric six-point Likert scale (0 = no symptoms, 5 = worst ever experienced). A composite score was then calculated as the sum of all previous elements, resulting in a total symptom score ranging from 0 to 25. Furthermore, general malaise was scored on an eleven-point scale (0 = no symptoms, 10 = worst ever experienced).

    Product #9433 – GMP LPS Lipopolysaccharide List™ Hpt™ From Escherichia Coli Type O113

Single-nucleus RNA sequencing unveils critical regulators in various hippocampal neurons for anti-N-methyl-D-aspartate receptor encephalitis

Bai, Y;Liu, Z;Qian, T;Peng, Y;Ma, H;Hu, H;Cheng, G;Wen, H;Xie, L;Zheng, D;Geng, Q;Wang, J;Wang, H;

Product: Pertussis Toxin from B. pertussis, Lyophilized in Buffer

  • The induction of the active immunization NMDAR mouse model

    C57BL/6 mice (10 weeks old, female) were immunized with GluN1356–385 extracellular peptides, which were emulsified in complete Freund’s adjuvant (CFA) and supplemented with mycobacterium tuberculosis H37Ra (4 mg/ml), and the final peptide concentration was 1 mg/ml. Mice were injected subcutaneously on the back with 200 μg of peptide in the emulsion mixture and received two enhanced injections with peptide emulsion at 4 and 8 weeks after the first immunization. Mice in the control group received an emulsion mixture of CFA and an equal volume of phosphate-buffered saline (PBS). All mice were intraperitoneally injected with 200 ng pertussis toxin (List Biological Laboratories) on the day of the last immunization and 48 h later. …

    Author did not specify which List Labs Pertussis Toxin was utilized. List Labs provides the following Pertussis Toxin products:
    Product #180 – Pertussis Toxin from B. pertussis, Lyophilized in Buffer
    Product #181 – Pertussis Toxin from B. pertussis, Lyophilized (Salt-Free)
    Product #179A – Pertussis Toxin from B. pertussis (in Glycerol)

Engineered probiotics limit CNS autoimmunity by stabilizing HIF-1? in dendritic cells

Sanmarco, LM;Rone, JM;Polonio, CM;Giovannoni, F;Lahore, GF;Ferrara, K;Gutierrez-Vazquez, C;Li, N;Sokolovska, A;Plasencia, A;Akl, CF;Nanda, P;Heck, ES;Li, Z;Lee, HG;Chao, CC;Rejano-Gordillo, CM;Fonseca-Castro, PH;Illouz, T;Linnerbauer, M;Kenison, JE;Barilla, RM;Farrenkopf, D;Piester, G;Dailey, L;Kuchroo, VK;Hava, D;Wheeler, MA;Clish, C;Nowarski, R;Balsa, E;Lora, JM;Quintana, FJ;

Product: Pertussis Toxin from B. pertussis, Lyophilized in Buffer

A melanopsin ganglion cell subtype forms a dorsal retinal mosaic projecting to the supraoptic nucleus

Berry, MH;Moldavan, M;Garrett, T;Meadows, M;Cravetchi, O;White, E;Leffler, J;von Gersdorff, H;Wright, KM;Allen, CN;Sivyer, B;

Product: Anti-Cholera Toxin B Subunit (Goat)

  • We used the following antibodies: … Goat anti-cholera toxin subunit B (List Labs – Cat#: 703); …

    … In our experiments, this antibody strongly amplifies the signal that is produced in mice where Cre drives the production of EGFP in specific neuronal populations (GlyT2Cre;Ai140; Ai140 from Jackson mouse line 030220). Goat anti-cholera toxin subunit B (List Labs – Cat#: 703; RRID AB_10013220) is a goat polyclonal antibody against the Cholera Toxin B subunit.

    Product #703 – Anti-Cholera Toxin B Subunit (Goat)

Product: Diphtheria Toxin, Unnicked, from Corynebacterium diphtheriae

HIV-1 remission and possible cure in a woman after haplo-cord blood transplant

Hsu, J;Van Besien, K;Glesby, MJ;Pahwa, S;Coletti, A;Warshaw, MG;Petz, L;Moore, TB;Chen, YH;Pallikkuth, S;Dhummakupt, A;Cortado, R;Golner, A;Bone, F;Baldo, M;Riches, M;Mellors, JW;Tobin, NH;Browning, R;Persaud, D;Bryson, Y;International Maternal Pediatric Adolescent AIDS Clinical Trials Network (IMPAACT) P1107 Team, ;

Product: Enterotoxin Type B from Staphylococcus aureus

  • HIV-1-specific T cell responses and assessment of T cell function

    Thawed PBMCs were rested overnight in RPMI-1640 medium with 10% fetal bovine serum a. The following day we stimulated 1.5 x
    106 PBMCs for 6 h in the presence of 2 mg/mL Gag potential T cell epitopes (PTE) peptides pool (AIDS Reagent Program, Division of AIDS, National Institute of Allergy and Infectious Diseases [NIAID], National Institutes of Health [NIH]. 1.5 x 106 PBMCs were simultaneously stimulated with staphylococcal enterotoxins B (SEB; List Biological Laboratories) at 1 mg/mL and another aliquot in the presence of media alone as the negative control. …